502 related articles for article (PubMed ID: 31211307)
21. Lipid Peroxidation and GPX4 Inhibition Are Common Causes for Myofibroblast Differentiation and Ferroptosis.
Gong Y; Wang N; Liu N; Dong H
DNA Cell Biol; 2019 Jul; 38(7):725-733. PubMed ID: 31140862
[TBL] [Abstract][Full Text] [Related]
22. Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS.
Wang L; Wang C; Li X; Tao Z; Zhu W; Su Y; Choi WS
Cell Mol Biol Lett; 2023 May; 28(1):36. PubMed ID: 37131152
[TBL] [Abstract][Full Text] [Related]
23. Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells.
Hao S; Yu J; He W; Huang Q; Zhao Y; Liang B; Zhang S; Wen Z; Dong S; Rao J; Liao W; Shi M
Neoplasia; 2017 Dec; 19(12):1022-1032. PubMed ID: 29144989
[TBL] [Abstract][Full Text] [Related]
24. GDF15 knockdown promotes erastin-induced ferroptosis by decreasing SLC7A11 expression.
Chen L; Qiao L; Bian Y; Sun X
Biochem Biophys Res Commun; 2020 May; 526(2):293-299. PubMed ID: 32209255
[TBL] [Abstract][Full Text] [Related]
25. Ferroptosis-inducing agents compromise in vitro human islet viability and function.
Bruni A; Pepper AR; Pawlick RL; Gala-Lopez B; Gamble AF; Kin T; Seeberger K; Korbutt GS; Bornstein SR; Linkermann A; Shapiro AMJ
Cell Death Dis; 2018 May; 9(6):595. PubMed ID: 29789532
[TBL] [Abstract][Full Text] [Related]
26. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
[TBL] [Abstract][Full Text] [Related]
27. Superparamagnetic Iron Oxide-Erastin-Polyethylene Glycol Nanotherapeutic Platform: A Ferroptosis-Based Approach for the Integrated Diagnosis and Treatment of Nasopharyngeal Cancer.
Tang H; Zhou X; Liu L; Wang Z; Wang C; Luo N; Jin G
Mol Pharm; 2024 Jun; 21(6):2767-2780. PubMed ID: 38736196
[TBL] [Abstract][Full Text] [Related]
28. MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells.
Gai C; Liu C; Wu X; Yu M; Zheng J; Zhang W; Lv S; Li W
Cell Death Dis; 2020 Sep; 11(9):751. PubMed ID: 32929075
[TBL] [Abstract][Full Text] [Related]
29. Assessment of zero-valent iron-based nanotherapeutics for ferroptosis induction and resensitization strategy in cancer cells.
Huang KJ; Wei YH; Chiu YC; Wu SR; Shieh DB
Biomater Sci; 2019 Mar; 7(4):1311-1322. PubMed ID: 30734774
[TBL] [Abstract][Full Text] [Related]
30. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
[TBL] [Abstract][Full Text] [Related]
31. Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells.
Li Y; Wang X; Chen YH; Tan QQ; Liu XB; Tan C
Anticancer Drugs; 2024 Mar; 35(3):227-236. PubMed ID: 38085677
[TBL] [Abstract][Full Text] [Related]
32. Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway.
Du Y; Bao J; Zhang MJ; Li LL; Xu XL; Chen H; Feng YB; Peng XQ; Chen FH
Gene; 2020 Sep; 755():144889. PubMed ID: 32534056
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of LONP1 protects against erastin-induced ferroptosis in Pancreatic ductal adenocarcinoma PANC1 cells.
Wang H; Liu C; Zhao Y; Zhang W; Xu K; Li D; Zhou Y; Li H; Xiao G; Lu B; Gao G
Biochem Biophys Res Commun; 2020 Feb; 522(4):1063-1068. PubMed ID: 31822343
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility to erastin-induced ferroptosis decreases during maturation in a human oligodendrocyte cell line.
Hoshino T; Yamakado H; Takahashi R; Matsuzawa SI
FEBS Open Bio; 2020 Sep; 10(9):1758-1764. PubMed ID: 32608563
[TBL] [Abstract][Full Text] [Related]
35. Erastin‑induced ferroptosis causes physiological and pathological changes in healthy tissues of mice.
Zhao J; Xu B; Xiong Q; Feng Y; Du H
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396451
[TBL] [Abstract][Full Text] [Related]
36. Arginine-Rich Manganese Silicate Nanobubbles as a Ferroptosis-Inducing Agent for Tumor-Targeted Theranostics.
Wang S; Li F; Qiao R; Hu X; Liao H; Chen L; Wu J; Wu H; Zhao M; Liu J; Chen R; Ma X; Kim D; Sun J; Davis TP; Chen C; Tian J; Hyeon T; Ling D
ACS Nano; 2018 Dec; 12(12):12380-12392. PubMed ID: 30495919
[TBL] [Abstract][Full Text] [Related]
37. Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma.
Yang Y; Luo M; Zhang K; Zhang J; Gao T; Connell DO; Yao F; Mu C; Cai B; Shang Y; Chen W
Nat Commun; 2020 Jan; 11(1):433. PubMed ID: 31974380
[TBL] [Abstract][Full Text] [Related]
38. Vitamin C induces ferroptosis in anaplastic thyroid cancer cells by ferritinophagy activation.
Wang X; Xu S; Zhang L; Cheng X; Yu H; Bao J; Lu R
Biochem Biophys Res Commun; 2021 Apr; 551():46-53. PubMed ID: 33714759
[TBL] [Abstract][Full Text] [Related]
39. Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.
Liu T; Liu W; Zhang M; Yu W; Gao F; Li C; Wang SB; Feng J; Zhang XZ
ACS Nano; 2018 Dec; 12(12):12181-12192. PubMed ID: 30458111
[TBL] [Abstract][Full Text] [Related]
40. The release and activity of HMGB1 in ferroptosis.
Wen Q; Liu J; Kang R; Zhou B; Tang D
Biochem Biophys Res Commun; 2019 Mar; 510(2):278-283. PubMed ID: 30686534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
